Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines.
Gallo M, Ferrari E, Terrazzan A, Brugnoli F, Spisni A, Taccioli C, Aguiari G, Trentini A, Volinia S, Keillor JW, Bergamini CM, Bianchi N, Pertinhez TA.
Gallo M, et al.
FEBS J. 2023 Nov;290(22):5411-5433. doi: 10.1111/febs.16931. Epub 2023 Aug 29.
FEBS J. 2023.
PMID: 37597264
Free article.